These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8697986)

  • 1. [A hot-spot mutation of p53 gene in nasopharyngeal carcinoma].
    Chen R; Zhu D; Yin W
    Zhonghua Zhong Liu Za Zhi; 1995 Nov; 17(6):401-4. PubMed ID: 8697986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of p53 gene mutations in primary nasopharyngeal carcinomas.
    Spruck CH; Tsai YC; Huang DP; Yang AS; Rideout WM; Gonzalez-Zulueta M; Choi P; Lo KW; Yu MC; Jones PA
    Cancer Res; 1992 Sep; 52(17):4787-90. PubMed ID: 1511442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of p53 mutations in primary nasopharyngeal carcinoma (NPC) in non-Asians of Los Angeles, California, a low-risk population for NPC.
    Van Tornout JM; Spruck CH; Shibata A; Schmutte C; Gonzalez-Zulueta M; Nichols PW; Chandrasoma PT; Yu MC; Jones PA
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):493-7. PubMed ID: 9232335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutation in human nasopharyngeal carcinomas.
    Lo KW; Mok CH; Huang DP; Liu YX; Choi PH; Lee JC; Tsao SW
    Anticancer Res; 1992; 12(6B):1957-63. PubMed ID: 1295443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of p53 gene in gastric carcinoma in Taiwan.
    Wang JY; Lin SR; Hsieh JS; Hsu CH; Huang YS; Huang TJ
    Anticancer Res; 2001; 21(1B):513-20. PubMed ID: 11299797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A lack of association between p53 mutations and recurrent nasopharyngeal carcinomas refractory to radiotherapy.
    Chang KP; Hao SP; Lin SY; Tsao KC; Kuo TT; Tsai MH; Tseng CK; Tsang NM
    Laryngoscope; 2002 Nov; 112(11):2015-9. PubMed ID: 12439172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 mutational spectrum of esophageal carcinomas from five different geographical locales in China.
    Lung ML; Chan WC; Zong YS; Tang CM; Fok CL; Wong KT; Chan LK; Lau KW
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):277-84. PubMed ID: 8722219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible association of p53 overexpression and mutation with high-grade chondrosarcoma.
    Dobashi Y; Sugimura H; Sato A; Hirabayashi T; Kanda H; Kitagawa T; Kawaguchi N; Imamura T; Machinami R
    Diagn Mol Pathol; 1993 Dec; 2(4):257-63. PubMed ID: 8118603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High frequency and heterogeneous distribution of p53 mutations in aflatoxin B1-induced mouse lung tumors.
    Tam AS; Foley JF; Devereux TR; Maronpot RR; Massey TE
    Cancer Res; 1999 Aug; 59(15):3634-40. PubMed ID: 10446974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nasopharyngeal carcinoma shows no detectable retinoblastoma susceptibility gene alterations.
    Sun Y; Hegamyer G; Colburn NH
    Oncogene; 1993 Mar; 8(3):791-5. PubMed ID: 8437863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident.
    Yamamoto S; Romanenko A; Wei M; Masuda C; Zaparin W; Vinnichenko W; Vozianov A; Lee CC; Morimura K; Wanibuchi H; Tada M; Fukushima S
    Cancer Res; 1999 Aug; 59(15):3606-9. PubMed ID: 10446970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutational analysis of p53 and RB2/p130 genes in Malaysian nasopharyngeal carcinoma samples: a preliminary report.
    Hoe SL; Sam CK
    Malays J Pathol; 2006 Jun; 28(1):35-9. PubMed ID: 17694957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma.
    Sun Y; Hegamyer G; Cheng YJ; Hildesheim A; Chen JY; Chen IH; Cao Y; Yao KT; Colburn NH
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6516-20. PubMed ID: 1631151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of p53 and ras gene mutations in DMBA-induced rat leukemias.
    Wei S; Kito K; Miyoshi A; Matsumoto S; Kauzi A; Aramoto T; Abe Y; Ueda N
    J Exp Clin Cancer Res; 2002 Sep; 21(3):389-96. PubMed ID: 12385583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of p53 abnormalities in endoscopic gastric biopsies.
    Imatani A; Sasano H; Asaki S; Toyota T; Saito M; Masuda T; Nagura H
    Anticancer Res; 1996; 16(4A):2049-56. PubMed ID: 8712741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
    Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P
    Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection of p53 mutation using PCR-SSCP silver staining method].
    Zhao W; Si J; Li K; Zhang X; Song G
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Jun; 17(3):219-22. PubMed ID: 8706159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 oncoprotein expression and gene mutations in some keratoacanthomas.
    Perez MI; Robins P; Biria S; Roco J; Siegel E; Pellicer A
    Arch Dermatol; 1997 Feb; 133(2):189-93. PubMed ID: 9041832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-CpG cytosine methylation of p53 exon 5 in non-small cell lung carcinoma.
    Kouidou S; Agidou T; Kyrkou A; Andreou A; Katopodi T; Georgiou E; Krikelis D; Dimitriadou A; Spanos P; Tsilikas C; Destouni H; Tzimagiorgis G
    Lung Cancer; 2005 Dec; 50(3):299-307. PubMed ID: 16125822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations clustered in exon 5 of the p53 gene in primary nasopharyngeal carcinomas from southeastern Asia.
    Chakrani F; Armand JP; Lenoir G; Ju LY; Liang JP; May E; May P
    Int J Cancer; 1995 May; 61(3):316-20. PubMed ID: 7729941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.